CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma

Background Patients with BRCA1-associated protein 1 (BAP1)-mutant clear cell renal cell carcinoma (ccRCC) have worse prognosis. C-C chemokine receptor 5 (CCR5) plays an important role in ccRCC development and its expression is elevated in BAP1-mutant tumors.Methods 533 patients with ccRCC from The C...

Full description

Saved in:

Bibliographic Details
Main Authors:	Li Liu, Quan Zhou, Yangyang Qi, Weijuan Zhang, Jiejie Xu, Yu Xia, Ying Xiong, Yu Zhu, Zewei Wang, Han Zeng, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Jiajun Wang, Yuan Chang, Yiwei Wang, Le Xu, Bo Dai, Qi Bai, Jianming Guo
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-05-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/8/1/e000228.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
by: Li Liu, et al.
Published: (2020-10-01)

Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture
by: Li Liu, et al.
Published: (2020-05-01)

Regulatory T cells in immune checkpoint blockade antitumor therapy
by: An Zhang, et al.
Published: (2024-11-01)

Blockade of CCR5+ T Cell Accumulation in the Tumor Microenvironment Optimizes Anti‐TGF‐β/PD‐L1 Bispecific Antibody
by: Ming Yi, et al.
Published: (2024-11-01)

Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure
by: Dahlia M. Nielsen, et al.
Published: (2025-01-01)

Diphtheria‐toxin based anti‐human CCR4 immunotoxin for targeting human CCR4+ cells in vivo
by: Zhaohui Wang, et al.
Published: (2015-08-01)

CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson’s disease models
by: Felipe Saceanu Leser, et al.
Published: (2025-02-01)

Regulation of Med1 protein by overexpression of BAP1 in breast cancer cells
by: Hyunju Kim
Published: (2024-12-01)

Endosulfan promotes cell growth, migration and invasion via CCL5/CCR5 axis in MCF-7 cells
by: Zeming Liu, et al.
Published: (2024-12-01)

Is Acteoside Effects on Colon Cancer Stem Cells Via Inflamation or Apoptosis?
by: Hafize Seda Vatansever, et al.
Published: (2022-08-01)

CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
by: Yi Zhang, et al.
Published: (2020-05-01)

Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model
by: Jun Wang, et al.
Published: (2020-10-01)

Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
by: Meixiang Wang, et al.
Published: (2025-01-01)

Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
by: Xia Liu, et al.
Published: (2022-10-01)

CCR2 signaling regulates anti-chlamydia T cell immune responses in the airway.
by: Shuaini Yang, et al.
Published: (2025-02-01)

WNT2 blockade augments antitumor immunity by attenuating myeloid‐derived suppressor cells in colorectal cancer
by: Cheng Cui, et al.
Published: (2024-12-01)

Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma
by: Lingling Li, et al.
Published: (2025-02-01)

Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
by: James Dooley, et al.
Published: (2021-02-01)

Eradication of HIV by Transplantation of CCR5-Deficient Hematopoietic Stem Cells
by: Gero Hütter, et al.
Published: (2011-01-01)

Mechanical Properties of Inflamed Appendix Tissues
by: Piotr Deptuła, et al.
Published: (2024-11-01)

Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
by: Weijuan Zhang, et al.
Published: (2025-01-01)

Optimizing T cell inflamed signature through a combination biomarker approach for predicting immunotherapy response in NSCLC
by: Yun-Ching Chen, et al.
Published: (2024-12-01)

NET formation-mediated in situ protein delivery to the inflamed central nervous system
by: Yina Wu, et al.
Published: (2024-12-01)

First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives
by: Qi He, et al.
Published: (2025-12-01)

TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion
by: Eliane Piaggio, et al.
Published: (2024-11-01)

A Para-Canalicular Abscess Resembling an Inflamed Chalazion
by: Diamantis Almaliotis, et al.
Published: (2013-01-01)

Ezrin drives adaptation of monocytes to the inflamed lung microenvironment
by: Ravindra Gudneppanavar, et al.
Published: (2024-11-01)

Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity
by: Dongjiao Wang, et al.
Published: (2024-03-01)

Publisher Correction: NET formation-mediated in situ protein delivery to the inflamed central nervous system
by: Yina Wu, et al.
Published: (2025-01-01)

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction
by: Marius Witt, et al.
Published: (2024-12-01)

The influence of immune checkpoint blockade on the outcomes of allogeneic hematopoietic stem cell transplantation
by: Yalei Hu, et al.
Published: (2024-11-01)

BRCA1-associated-protein 1 tumour predisposition syndrome (BAP1-TPDS) presenting with multiple BAP1-inactivated melanocytic tumours – a rare hereditary tumour syndrome
by: C.H. Loh, et al.
Published: (2024-01-01)

Increased CCR7loPD-1hiCXCR5+CD4+ T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection
by: Ya-Xin Huang, et al.
Published: (2018-01-01)

The Link between Type III Reg and STAT3-Associated Cytokines in Inflamed Colonic Tissues
by: Xin Xu, et al.
Published: (2019-01-01)

Macrophage depletion in inflamed rat knees prevents the activation of synovial mesenchymal stem cells by weakening Nampt and Spp1 signaling
by: Hayato Kodama, et al.
Published: (2024-11-01)

Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
by: Cheng Xu, et al.
Published: (2023-04-01)

Inflamed Mesenteric Pseudocyst Associated with Meckel’s Diverticulitis: Cause or Consequence
by: Stefan Talev, et al.
Published: (2024-12-01)

Progress on effects of BaP exposure on female reproductive system and pathogenic mechanisms
by: Qianqian GAO, et al.
Published: (2024-12-01)

CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy
by: Ayush Pant, et al.
Published: (2024-12-01)

NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
by: Ismail M Meraz, et al.
Published: (2025-02-01)